Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.

Accumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in...

Full description

Bibliographic Details
Main Authors: Martin L Decaris, Claire L Emson, Kelvin Li, Michelle Gatmaitan, Flora Luo, Jerome Cattin, Corelle Nakamura, William E Holmes, Thomas E Angel, Marion G Peters, Scott M Turner, Marc K Hellerstein
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4409311?pdf=render
id doaj-fe048d345f2146f3b9f24b26786a70a7
record_format Article
spelling doaj-fe048d345f2146f3b9f24b26786a70a72020-11-25T01:55:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012331110.1371/journal.pone.0123311Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.Martin L DecarisClaire L EmsonKelvin LiMichelle GatmaitanFlora LuoJerome CattinCorelle NakamuraWilliam E HolmesThomas E AngelMarion G PetersScott M TurnerMarc K HellersteinAccumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in vivo metabolic labeling to measure the turnover rate of hepatic collagen and collagen-associated proteins in plasma for the first time in human subjects. Eight subjects with chronic liver disease were labeled with daily oral doses of 2H2O for up to 8 weeks prior to diagnostic liver biopsy and plasma collection. Tandem mass spectrometry was used to measure the abundance and fractional synthesis rate (FSR) of proteins in liver and blood. Relative protein abundance and FSR data in liver revealed marked differences among subjects. FSRs of hepatic type I and III collagen ranged from 0.2-0.6% per day (half-lives of 4 months to a year) and correlated significantly with worsening histologic fibrosis. Analysis of plasma protein turnover revealed two collagen-associated proteins, lumican and transforming growth factor beta-induced-protein (TGFBI), exhibiting FSRs that correlated significantly with FSRs of hepatic collagen. In summary, this is the first direct measurement of liver collagen turnover in vivo in humans and suggests a high rate of collagen remodeling in advanced fibrosis. In addition, the FSRs of collagen-associated proteins in plasma are measurable and may provide a novel strategy for monitoring hepatic fibrogenesis rates.http://europepmc.org/articles/PMC4409311?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Martin L Decaris
Claire L Emson
Kelvin Li
Michelle Gatmaitan
Flora Luo
Jerome Cattin
Corelle Nakamura
William E Holmes
Thomas E Angel
Marion G Peters
Scott M Turner
Marc K Hellerstein
spellingShingle Martin L Decaris
Claire L Emson
Kelvin Li
Michelle Gatmaitan
Flora Luo
Jerome Cattin
Corelle Nakamura
William E Holmes
Thomas E Angel
Marion G Peters
Scott M Turner
Marc K Hellerstein
Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
PLoS ONE
author_facet Martin L Decaris
Claire L Emson
Kelvin Li
Michelle Gatmaitan
Flora Luo
Jerome Cattin
Corelle Nakamura
William E Holmes
Thomas E Angel
Marion G Peters
Scott M Turner
Marc K Hellerstein
author_sort Martin L Decaris
title Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
title_short Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
title_full Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
title_fullStr Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
title_full_unstemmed Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
title_sort turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Accumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in vivo metabolic labeling to measure the turnover rate of hepatic collagen and collagen-associated proteins in plasma for the first time in human subjects. Eight subjects with chronic liver disease were labeled with daily oral doses of 2H2O for up to 8 weeks prior to diagnostic liver biopsy and plasma collection. Tandem mass spectrometry was used to measure the abundance and fractional synthesis rate (FSR) of proteins in liver and blood. Relative protein abundance and FSR data in liver revealed marked differences among subjects. FSRs of hepatic type I and III collagen ranged from 0.2-0.6% per day (half-lives of 4 months to a year) and correlated significantly with worsening histologic fibrosis. Analysis of plasma protein turnover revealed two collagen-associated proteins, lumican and transforming growth factor beta-induced-protein (TGFBI), exhibiting FSRs that correlated significantly with FSRs of hepatic collagen. In summary, this is the first direct measurement of liver collagen turnover in vivo in humans and suggests a high rate of collagen remodeling in advanced fibrosis. In addition, the FSRs of collagen-associated proteins in plasma are measurable and may provide a novel strategy for monitoring hepatic fibrogenesis rates.
url http://europepmc.org/articles/PMC4409311?pdf=render
work_keys_str_mv AT martinldecaris turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT clairelemson turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT kelvinli turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT michellegatmaitan turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT floraluo turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT jeromecattin turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT corellenakamura turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT williameholmes turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT thomaseangel turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT mariongpeters turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT scottmturner turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
AT marckhellerstein turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease
_version_ 1724982836798160896